Speech-in-Noise as a Biomarker of Peripheral Auditory Neuropathy in Metabolic Disorders: Proof of Concept in Patients with Uncontrolled Type 2 Diabetes
The DIAMANT study reports hearing phenotypes encountered in patient with type-2 diabetes, with a particular focus on subclinical hearing loss associated with speech-in-noise intelligibility deficit.

